Myocardium From Patients With ATTR Amyloidosis Produces Less Force Secondary to Increased Fibrosis
Amyloid transthyretin cardiac amyloidosis is one of the most common infiltrative cardiomyopathies. Contractile, biochemical, and histological assays were performed on myocardium from patients with and without amyloid transthyretin amyloidosis. Force was reduced in amyloidosis, but calcium sensitivity was increased. The change in calcium sensitivity may reflect dephosphorylation of troponin I. The proportion of stiffness attributable to the extracellular matrix was larger in amyloidosis. Septal fibrosis and amyloid burden correlated with measurements from LV samples. Technetium pyrophosphate scans may detect increased microcalcifications in amyloidosis myocardium. Replacement of myocytes with extracellular matrix is the most important factor depressing contractile force in amyloidosis myocardium.
Authors
- Gregory Milburn (ORCID: https://orcid.org/0000-0001-5547-2441)
- Kenneth S. Campbell (ORCID: https://orcid.org/0000-0001-5615-5958)
- Andrew Yackzan
- Austin G. Wellette‐Hunsucker (ORCID: https://orcid.org/0000-0002-4198-2456)
- Jania Bell
- Hollings Ruml
Institutions
- University of Kentucky (US)
Publication Details
- Journal
- JACC Basic to Translational Science
- Published
- 2025-05-08
- DOI
- https://doi.org/10.1016/j.jacbts.2025.03.003
- Citations
- 2
- Primary Topic
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 1.61
Funders
- American Heart Association
- National Institutes of Health